Evidence map›Paper›PMID 26677224›Full record

ArticleThe Journal of biological chemistry2016

Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy.

Georg Künze, Sebastian Köhling, Alexander Vogel, Jörg Rademann, Daniel Huster

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Modeling Protein-Glycosaminoglycan Complexes: Does the Size Matter?Journal of chemical information and modeling · 2021
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. ImprovedFrontiers in molecular biosciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Georg KünzeFrom the Institute of Medical Physics and Biophysics, University of Leipzig, Härtelstrasse 16/18, 04107 Leipzig, Germany and.
Sebastian KöhlingFrom the Institute of Medical Physics and Biophysics, University of Leipzig, Härtelstrasse 16/18, 04107 Leipzig, Germany and the Institute of Pharmacy, Medicinal Chemistry, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195 Berlin, Germany.
Alexander VogelFrom the Institute of Medical Physics and Biophysics, University of Leipzig, Härtelstrasse 16/18, 04107 Leipzig, Germany and.
Jörg RademannFrom the Institute of Medical Physics and Biophysics, University of Leipzig, Härtelstrasse 16/18, 04107 Leipzig, Germany and the Institute of Pharmacy, Medicinal Chemistry, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195 Berlin, Germany.
Daniel HusterFrom the Institute of Medical Physics and Biophysics, University of Leipzig, Härtelstrasse 16/18, 04107 Leipzig, Germany and daniel.huster@medizin.uni-leipzig.de.
Leipzig University · DEFreie Universität Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biological function of interleukin-10 (IL-10), a pleiotropic cytokine with an essential role in inflammatory processes, is known to be affected by glycosaminoglycans (GAGs). GAGs are highly negatively charged polysaccharides and integral components of the extracellular matrix with important functions in the biology of many growth factors and cytokines. The molecular mechanism of the IL-10/GAG interaction is unclear. In particular, experimental evidence about IL-10/GAG binding sites is lacking, despite its importance for understanding the biological role of the interaction. Here, we report the experimental determination of a GAG binding site of IL-10. Although no co-crystal structure of the IL-10·GAG complex could be obtained, its structural characterization was possible by NMR spectroscopy. Chemical shift perturbations of IL-10 induced by GAG binding were used to narrow down the location of the binding site and to assess the affinity for different GAG molecules. Subsequent observation of NMR pseudocontact shifts of IL-10 and its heparin ligand, as induced by a protein-attached lanthanide spin label, provided structural restraints for the protein·ligand complex. Using these restraints, pseudocontact shift-based rigid body docking together with molecular dynamics simulations yielded a GAG binding model. The heparin binding site is located at the C-terminal end of helix D and the adjacent DE loop and coincides with a patch of positively charged residues involving arginines 102, 104, 106, and 107 and lysines 117 and 119. This study represents the first experimental characterization of the IL-10·GAG complex structure and provides the starting point for revealing the biological significance of the interaction of IL-10 with GAGs.

Indexed as

Models, MolecularAnimalsBinding SitesCrystallography, X-RayGlycosaminoglycansInterleukin-10MiceNuclear Magnetic Resonance, BiomolecularglucosaminoglycansGlycosaminoglycansIL10 protein, mouseInterleukin-10carbohydrate functionextracellular matrixglycosaminoglycanheparininterleukin-10nuclear magnetic resonance (NMR)paramagnetic NMRpseudocontact shifts

Identifiers

PMID26677224
PMCPMC4742770
OpenAlexW2208597804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.